FDA Approves Polypill Widaplik for Hypertension
Physician's Weekly
JUNE 11, 2025
Food and Drug Administration has approved Widaplik (telmisartan, amlodipine, and indapamide) for the treatment of hypertension in adults. Widaplik is not to be coadministered with aliskiren in patients with diabetes, and a boxed warning indicates discontinuation of Widaplik during pregnancy. and worldwide,” Paul Whelton, M.D.,
52 
Let's personalize your content